References
- Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, Lowell BB. 2002. /3AR signaling required for diet-induced thermogenesis and obesity resistance. Science 297:843–845.
- Cawthorne MA, Sennitt MV, Arch JR, Smith SA. 1992. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist. American Journal of Clinical Nutrition 55:252S–257S.
- Chay SH, Pohland RC. 1994. Comparison of quantitative whole-body autoradiographic and tissue dissection techniques in the evaluation of the tissue distribution of [14C] daptomycin in rats. Journal of Pharmacology Science 83:1294–1299.
- Connacher AA, Bennet WM, Jung RT, Rennie MJ. 1992. Metabolic effects of three weeks administration of the beta-adrenoceptor agonist BRL 26830A. International Journal of Obesity and Related Metabolic Disorders 16:685–694.
- Connacher AA, Bennet WM, Jung RT. 1992. Clinical studies with the beta-adrenoceptor agonist BRL 26830A. American Journal of Clinical Nutrition 55(1 Suppl.):2585–2615.
- De Souza CJ, Burkey BF. 2001. Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Current Pharmaceutical Design 7:1433–1449.
- Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science 245:1118–1121.
- Granneman JG, Lahners KN, Rao DD. 1992. Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block. Molecular Pharmacology 42:964–970.
- He MM, Barbuch RJ, Abraham TL, Lindsay TJ, Jackson DA, Ackermann BL, Wilke AV, Jensen CB. 2003. Characterization of dark liver pigment observed in rats after subchronic dosing of the /3-3 adrenergic receptor agonist LY368842. Chemical Research in Toxicology 16:912–919.
- Howe R, Rao BS, Holloway BR, Stribling D. 1992. Selective beta 3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4- [2- [(2-Hydroxy-3-phenoxypropyl)amino] ethoxy] phenoxy] acetates. Journal of Medicinal Chemistry 35:1751–1759.
- Johnston RF, Pickett SC, Barker DL. 1990. Autoradiography using storage phosphor technology. Electrophoresis 11:355–360.
- Lonnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Amer P. 1993. Evidence for a functional beta 3-adrenoceptor in man. British Journal of Pharmacology 110:929–936.
- Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Amer P. 1995. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. Journal of Clinical Investigation 95:1109–1116.
- Lowell BB, Bachman ES. 2003. Beta 3-adrenergic receptors, diet-induced thermogenesis, and obesity. Journal of Biological Chemistry 278L 29385–29388.
- Mitchell TH, Ellis RD, Smith SA, Robb G, Cawthome MA. 1989. Effects of BRL 35135, a beta-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects. International Journal of Obesity 13:757–766.
- Tan S, Curtis-Prior PB. 1983. Characterization of the beta-adrenoceptor of the adipose cell of the rat. International Journal of Obesity 7:409–414.
- Ullberg S. 1977. The technique of whole-body autoradiography: cryosectioning of large specimens. Science Tools [LKB Instrument Journal: Special Issue]: 2–29.
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–431.